With pivotal Phase III data for lead candidate ThermoDox about a year away, Celsion is preparing to transition from a clinical-stage company into a commercial operation. The biotech, currently based in Columbia, Md., will be moving to New Jersey early next quarter as it prepares to double its staff over the next year.
Continue reading "Coming In Thursday's "The Pink Sheet" DAILY - Celsion Begins Transition To A Commerical Stage Company" »
Biotech will combine its SVP platform technology with a SAIC-developed antigen to try to find the key to treating malaria.
read more
Continue reading "Latest News From "The Pink Sheet" DAILY - Selecta To Combine Forces With SAIC On Malaria Work" »
Article preview from "PharmAsia News"- August 30, 2011
NEW DELHI - As part of a comprehensive overhaul, India's Department of Ayush, which deals with the Indian traditional system of medicine, locally known as ayurveda, has decided to close 180 ayurveda-based medical colleges that have not been operating according to prescribed standards.
Continue reading "India Moves To Close Traditional Medicine Colleges Not Operating According To Standards " »
Mortality benefit data could give Bristol-Myers Squibb and Pfizer’s apixaban a leg up over other novel oral anticoagulants.
Continue reading "Coming In Tuesday's "The Pink Sheet" DAILY - How BMS/Pfizer's Apixaban Stacks up To The Competition" »
Article preview from "The Pink Sheet"- August 29, 2011
Now that Seattle Genetics Inc. is making the transition into a commercial drug company with the FDA approval of its oncologic Adcetris, its success will depend on how effectively it can convince payers, patients and physicians that Adcetris is worth its premium price and how well it can extend the drug’s reach to larger patient markets.
Continue reading "Seattle Genetics Will Test Oncology Pricing Acceptance With Adcetris" »
Xalkori is the second targeted oncologic approved with a companion diagnostic this year, FDA says, following Roche's Zelboraf just 10 days prior.
read more
Continue reading "Latest News From "The Pink Sheet" DAILY - Pfizer Wins FDA Approval For Xalkori" »